Your Patients Can't Find Carafate — Here's How You Can Help

Patients are showing up to appointments frustrated. They've been told their pharmacy is out of Carafate (Sucralfate), they've called multiple locations, and they're running low on medication. As a provider, you're in a unique position to help — not just by prescribing alternatives, but by arming patients with tools and strategies to locate the medication they need.

This guide outlines the current availability landscape, explains why patients are struggling, and gives you five concrete steps to integrate into your workflow.

Current Availability of Carafate

The Sucralfate shortage has been driven primarily by intermittent supply disruptions from Teva Pharmaceuticals, one of the largest producers of generic Sucralfate 1-gram tablets. Teva has attributed the shortage to increased demand and has been releasing inventory in waves rather than maintaining consistent supply.

Viatris (Mylan) continues to manufacture Sucralfate tablets without interruption, but a single manufacturer's output is often insufficient to cover national demand. The oral suspension (1g/10mL) has experienced fewer supply issues than tablets but is not immune to periodic shortages.

Key takeaways on current availability:

• Supply is intermittent, not absent — Sucralfate is still being produced
• Availability varies significantly by region, pharmacy chain, and formulation
• Independent pharmacies with access to secondary wholesalers tend to have better fill rates
• Mail-order pharmacies may maintain larger buffer stock

Why Patients Can't Find It

Understanding the barriers helps you counsel patients more effectively:

Most Patients Only Check One Pharmacy

The typical patient tries their regular pharmacy, gets told it's out of stock, and feels stuck. They may not know they can transfer prescriptions, try independent pharmacies, or use real-time search tools.

Chain Pharmacies Are Hit Hardest

Large retail chains rely on centralized wholesale distribution, and lower-margin generics like Sucralfate may not receive priority restocking. Independent pharmacies with diverse supplier relationships often fare better.

Patients Don't Know About Formulation Options

Many patients don't realize Carafate comes in both tablet and suspension forms. If their prescription specifies one formulation, the pharmacy can't automatically substitute the other without a new prescription or provider authorization.

Cost Confusion Adds a Barrier

Even when patients find Sucralfate, the price without insurance ($50–$150+ for generic, over $700 for brand) can cause sticker shock. Patients may not know about discount programs that reduce the cost to as little as $13–$27.

What Providers Can Do: 5 Actionable Steps

Step 1: Write Formulation-Flexible Prescriptions

When prescribing Sucralfate, note on the prescription that either the tablet (1g) or oral suspension (1g/10mL) is acceptable. This simple step gives the dispensing pharmacist authority to fill whichever formulation is available without needing to call your office for a new prescription.

Example prescription note: "Sucralfate 1g QID on empty stomach. Tablet or suspension acceptable."

Step 2: Direct Patients to Medfinder

Medfinder is a free tool that shows real-time pharmacy availability for medications by zip code. You can:

• Recommend patients search at medfinder.com before going to the pharmacy
• Use the provider portal during the visit to help patients identify pharmacies with stock
• Include Medfinder in patient handouts or after-visit summaries about the shortage

Step 3: Document a Therapeutic Backup in the Chart

Record a pre-approved alternative in case the patient cannot locate Sucralfate at any pharmacy. This prevents delays when the patient needs to switch quickly. A sample documentation approach:

"Patient started on Sucralfate 1g QID for active duodenal ulcer. If unavailable, may substitute Omeprazole 20mg daily. Patient counseled on shortage and given Medfinder information."

Common therapeutic alternatives to document:

• Omeprazole 20–40mg daily — First-line PPI for ulcer healing
• Famotidine 20mg BID or 40mg HS — H2 blocker alternative
• Esomeprazole 20–40mg daily — Alternative PPI
• Misoprostol 200mcg QID — For NSAID-induced ulcer prophylaxis (not in pregnancy)

Step 4: Recommend Independent and Specialty Pharmacies

When counseling patients, specifically mention that independent pharmacies may have better access to Sucralfate than chain stores. If your practice has relationships with local independent pharmacies, share those names directly.

Other options to suggest:

• Compounding pharmacies for custom Sucralfate preparations
• Hospital outpatient pharmacies if accessible to the patient
• Mail-order pharmacies (Amazon Pharmacy, Costco, or insurance plan mail-order) for planned refills

Step 5: Address Cost Proactively

Many patients won't mention cost as a barrier unless asked. When prescribing Sucralfate, briefly mention:

• Generic Sucralfate is available and costs $13–$27 with discount coupons (GoodRx, SingleCare)
• Prescription Hope offers Sucralfate at $70/month through patient assistance programs
• Most insurance plans cover generic Sucralfate with a $0–$20 copay

For a patient-friendly savings overview, direct them to How to Save Money on Carafate.

Therapeutic Alternatives at a Glance

When substitution is necessary, here's a quick reference:

• For active duodenal/gastric ulcers: Omeprazole 20–40mg daily (PPI) or Famotidine 40mg HS (H2 blocker)
• For GERD in pregnancy: Famotidine is preferred; Sucralfate is also safe per ACG guidelines if available
• For NSAID gastroprophylaxis: Misoprostol 200mcg QID or Omeprazole 20mg daily
• For mucositis: Limited direct alternatives; consider "magic mouthwash" compounded preparations or topical lidocaine for oral mucositis
• For stress ulcer prophylaxis (ICU): Famotidine IV or Pantoprazole IV per institutional protocol

Note that PPIs and H2 blockers work through acid suppression rather than mucosal protection — a clinically relevant distinction for patients specifically selected for Sucralfate's barrier mechanism. See our alternatives guide for more detail.

Workflow Tips for Your Practice

• Add a Sucralfate shortage note to your EHR — A pop-up or smart phrase can remind staff to discuss the shortage at the point of prescribing
• Pre-print patient handouts about the shortage with Medfinder information and a list of local independent pharmacies
• Train front-desk staff to refer patients reporting unfilled Sucralfate prescriptions to medfinder.com rather than defaulting to "call your pharmacy"
• Set up a therapeutic substitution protocol so nursing staff can facilitate switches without requiring a full provider visit

Final Thoughts

The Sucralfate shortage adds an operational burden to already-busy practices, but small workflow adjustments can make a significant difference for patients. Formulation-flexible prescribing, pre-documented alternatives, and directing patients to Medfinder are the highest-impact actions you can take.

For a broader overview of the shortage and its timeline, see our provider shortage briefing. For cost-focused guidance to share with patients, see how to help patients save money on Carafate.